Neoadjuvant immunotherapy with combined ipilimumab and nivolumab in patients with melanoma with primary or in transit disease. [electronic resource]
- The British journal of dermatology 09 2020
- 559-563 p. digital
Publication Type: Case Reports; Journal Article
1365-2133
10.1111/bjd.18739 doi
Antineoplastic Combined Chemotherapy Protocols--therapeutic use Humans Immunotherapy Ipilimumab--therapeutic use Melanoma--drug therapy Neoadjuvant Therapy Nivolumab--therapeutic use